30.01.2018 Views

Global Clinical Trial Market

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

According to the report "<strong>Global</strong> <strong>Clinical</strong> <strong>Trial</strong> <strong>Market</strong>”, published by published by Industry Data Forecast,<br />

The industry has been estimated at USD 21.41 billion by 2021, at a CAGR of 7.75% from 2016 to 2021.<br />

<strong>Clinical</strong> <strong>Trial</strong>s are research studies performed on humans to gain specific information about biomedical<br />

interventions such as novel vaccines, devices, treatments and drugs and thereby generating safety data.<br />

They are conducted in four phases namely, Phase I, II, III and IV. It is mandatory for further approval of<br />

the drug and to bring it into the market.<br />

The market for <strong>Clinical</strong> <strong>Trial</strong>s is mainly driven due to advancement in technology, increasing demand of<br />

innovative solutions in healthcare industry, and further boosted the alliances between the pharmbiotech<br />

companies and the clinical research organizations. But, the market growth can be hampered<br />

due to factors such as lack of skilled professionals to operate advanced CTMS solutions and budget<br />

constraints of small- and medium-sized pharmaceutical and biotechnology companies and small CROs.<br />

Browse market data tables and in-depth TOC of the <strong>Clinical</strong> <strong>Trial</strong> <strong>Market</strong> Industry to 2021 @<br />

http://www.marketdataforecast.com/market-reports/global-clinical-trials-market-1651/<br />

<strong>Global</strong> market for <strong>Clinical</strong> <strong>Trial</strong>s is segmented based on Phase, design and indication. By Phase, the<br />

market is further sub-segmented into Phase I, Phase II, and Phase III. By design, the market is further<br />

sub-segmented into Interventional trials, Observational trials, Expanded Access trials. By indication, the<br />

market is further sub-segmented into Autoimmune, Blood disorders, Cancer, Circulatory, CNS,<br />

Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental disorders,<br />

Metabolic, Musculoskeletal, Nose, Ophthalmology. Cancer and CNS are the largest market share<br />

contributors to the market. Segments like Gastrointestinal, Circulatory, Dermatology and Mental<br />

Disorders are moving with high CAGR due to their increasing occurrence.<br />

Geographically, <strong>Global</strong> market for <strong>Clinical</strong> <strong>Trial</strong>s is segmented into North America, Asia Pacific, Latin<br />

America, Europe, and Middle-East and Africa. North America is the biggest market in terms of market<br />

share across the globe, followed by Europe. Ample availability of funds to outsource <strong>Clinical</strong> <strong>Trial</strong>s serves<br />

as the major growth driver for the North America. The spread of analytics and awareness of its potential<br />

are increasing at a rapid rate in Europe. The <strong>Clinical</strong> <strong>Trial</strong>s market in the Asia-Pacific region is projected<br />

to grow at the highest CAGR, which is greatly due to initiatives from the government and contributions<br />

from academic laboratories, which helped augment growth.<br />

Free sample of the report is available @http://www.marketdataforecast.com/marketreports/global-clinical-trials-market-1651/request-sample<br />

Key Points from Table of Contents<br />

Overview:<br />

3. Overview<br />

3.1 Executive Summary<br />

3.2 Key Inferences


3.3 New Developments<br />

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)<br />

5. Industry Segmentation<br />

Based on Phase<br />

Based on Design<br />

Based on Indications<br />

6. Geographical Analysis<br />

7. Pipeline Product Analysis<br />

8. Strategic Analysis<br />

8.1 PESTLE analysis<br />

8.2 Porter’s five analysis<br />

9. Industry Leaders' Analysis<br />

10. Competitive Landscape<br />

Geographical Segmentation:<br />

North America <strong>Clinical</strong> <strong>Trial</strong> <strong>Market</strong><br />

Europe <strong>Clinical</strong> <strong>Trial</strong> <strong>Market</strong><br />

Asia-Pacific <strong>Clinical</strong> <strong>Trial</strong> <strong>Market</strong><br />

Latin America <strong>Clinical</strong> <strong>Trial</strong> <strong>Market</strong><br />

Middle-East and Africa <strong>Clinical</strong> <strong>Trial</strong> <strong>Market</strong><br />

The major companies operating in the global <strong>Clinical</strong> <strong>Trial</strong> <strong>Market</strong> are Chiltern (U.K.), Omnicare (U.S.),<br />

PPD (U.S.), Parexel (U.S.), Kendle (U.S.), Quintles (U.S.), ICON Plc (Ireland), and Charles River(U.S.),<br />

Enquire more about the report here http://www.marketdataforecast.com/marketreports/global-clinical-trials-market-1651/inquire<br />

The <strong>Clinical</strong> <strong>Trial</strong> market study offers the following deliverables:<br />

<strong>Global</strong>, regional and country-level analysis and forecasts of the study market; providing Insights on<br />

the major countries/regions in which this industry is blooming and to also identify the regions that are<br />

still untapped


Segment-level analysis in terms of technology, component, and type along with market size forecasts<br />

and estimations to detect key areas of industry growth in detail<br />

Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their<br />

impact on shifting market dynamics<br />

Study of the effect of exogenous and endogenous factors that affect the global market; which includes<br />

broadly demographic, economics, and political, among other macro-environmental factors presented in<br />

an extensive PESTLE Analysis<br />

Study the micro environment factors that determine the overall profitability of an Industry,<br />

using Porter’s five forces analysis for analyzing the level of competition and business strategy<br />

development<br />

A comprehensive list of key market players along with their product portfolio, current strategic<br />

interests, key financial information, legal issues, SWOT analysis and analyst overview to study and<br />

sustain the market environment<br />

Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along<br />

with new product launches, comparative financial studies and recent developments in the market by the<br />

major companies<br />

An executive summary, abridging the entire report in such a way that decision-making personnel can<br />

rapidly become acquainted with background information, concise analysis and main conclusions<br />

Expertly devised analyst overview along with Investment opportunities to provide both individuals<br />

and organizations a strong financial foothold in the market<br />

About Us:<br />

<strong>Market</strong> Data Forecast is a firm working in the area of market research and business intelligence. With<br />

rich experience in research across various business domains, we cater to the needs of both individual<br />

and corporate clients. Our analyst team comprises expert professionals in market research, who with<br />

their collective knowledge and skillset dedicatedly serve clients from various industries and regions.<br />

Contact:<br />

Abhishek Shukla<br />

Team Lead (International Business Development)<br />

<strong>Market</strong> Data Forecast<br />

Direct Line: +1-888-702-9626


Mobile: +91 998 555 0206<br />

Mail: abhishek@marketdataforecast.com<br />

Visit <strong>Market</strong>DataForecast Blog @ http://www.marketdataforecast.com/blog/<br />

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!